Search Result "potential HDACis."
QSAR and Docking Studies on Different Series of Histone Deacetylase Inhibitors (HDACIs)
Journal: Letters in Drug Design & Discovery
Volume: 9 Issue: 4 Year: 2012 Page: 367-378
Author(s): Yuhong Xiang, Liang Zhang, Zhuoyong Zhang
Histone Deacetylase Inhibitors as Potential Therapeutic Agents for the Treatment of Malignant Mesothelioma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 3 Year: 2013 Page: 476-482
Author(s): Patroklos Katafygiotis,Constantinos Giaginis,Efstratios Patsouris,Stamatios Theocharis
Modulation of TRAIL-Induced Apoptosis by HDAC Inhibitors
Journal: Current Cancer Drug Targets
Volume: 8 Issue: 2 Year: 2008 Page: 132-140
Author(s): Simone Fulda
The Pharmaceutical Potential of Histone Deacetylase Inhibitors
Journal: Current Pharmaceutical Design
Volume: 13 Issue: 2 Year: 2007 Page: 2584-2620
Author(s): Greetje Elaut, Vera Rogiers, Tamara Vanhaecke
Development of an Efficient Screening System for HDAC Inhibitor Based on TCF Response Element
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2018 Page: 2131-2136
Author(s): Limeng Dai,Chen Pang,Gang He,You Lu,Bo Zhang
Developing Histone Deacetylase Inhibitors as Anti-Cancer Therapeutics
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 1658-1671
Author(s): B. Venugopal, T.R.J. Evans
Histone Acetylation as a Potential Therapeutic Target in Motor Neuron Degenerative Diseases
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 5093-5104
Author(s): Lutz Garbes, Markus Riessland, Brunhilde Wirth
Histone Deacetylase Inhibitors Modulating Non-epigenetic Players: The Novel Mechanism for Small Molecule Based Therapeutic Intervention
Journal: Current Drug Targets
Volume: 19 Issue: 6 Year: 2018 Page: 593-601
Author(s): Shabir Ahmad Ganai
The Safety, Efficacy and Therapeutic Potential of Histone Deacetylase Inhibitors with Special Reference to Panobinostat in Gastrointestinal Tumors: A Review of Preclinical and Clinical Studies
Journal: Current Cancer Drug Targets
Volume: 18 Issue: 8 Year: 2018 Page: 720-736
Author(s): Avineesh Singh,Preeti Patel,Jageshwar,Vijay Kumar Patel,Deepak Kumar Jain,M. Kamal,Harish Rajak
YF343, A Novel Histone Deacetylase Inhibitor, Combined with CQto Inhibit- Autophagy, Contributes to Increased Apoptosis in Triple-Negative Breast Cancer
Journal: Current Medicinal Chemistry
Volume: 30 Issue: 40 Year: 2023 Page: 4605-4621
Author(s):